连续股神经阻滞与收肌管阻滞用于前交叉韧带手术:双盲优效性随机对照试验
该单中心双盲优效性随机对照试验纳入60例前交叉韧带重建成人患者,比较连续股神经阻滞(CFNB)与连续收肌管阻滞(CACB)的镇痛效果。主要结局48小时平均NRS疼痛评分两组无显著差异,CFNB在术后当天即时疼痛较低,探索性分析显示CFNB组需要>50 MME的患者较少。
要点
- CFNB与CACB在48小时平均NRS疼痛评分上无显著差异。
- CFNB组术后当天即时NRS疼痛评分较低。
- 探索性分析显示CFNB组需要>50 MME的患者比例较低。
核心结论
- CFNB在48小时主要疼痛结局上不优于CACB。
- CFNB导管与较低的术后即时疼痛相关。
- 探索性分析中CFNB组需要更多吗啡毫克当量(>50 MME)的患者较少,但需足够把握度的试验证实。
研究设计与样本
- 单中心、双盲、前瞻性、优效性随机对照试验,纳入60例接受前交叉韧带重建的成人患者。
- 随机分为CFNB组或CACB组,所有患者接受20 mL 0.5%罗哌卡因负荷剂量,并出院时携带0.2%罗哌卡因输注(基础5 mL/小时,需求 Bolus 5 mL,锁定30分钟)。
- 57例患者完成研究(CFNB n=28;CACB n=29)。
主要发现
- 48小时平均NRS疼痛评分混合效应重复测量分析显示CFNB与CACB无显著差异,总体治疗效果估计为-0.31 NRS分(p=0.58,95%CI -1.39至0.77),无显著治疗-时间交互作用(p=0.97)。
- CFNB组术后当天(POD0)当前NRS疼痛评分较低(p=0.02,95%CI 6.44×10-6至2.00)。
- 探索性分析中,48小时随访期间需要>50 MME的患者CFNB组为5/28,CACB组为13/29(p=0.045,95%CI 0.08至0.93),绝对风险差为0.27(95%CI -0.08至0.54)。
- 连续被动运动(CPM)使用或依从性、Bolus量或QoR-15评分无差异。
临床怎么用
- CFNB与CACB均可用于前交叉韧带重建术后镇痛,主要疼痛结局无差异。
- 若关注术后即时疼痛控制,CFNB可能提供更低的POD0疼痛评分。
- CFNB可能减少需要>50 MME的患者比例,但证据为探索性,需进一步验证。
局限性
- 探索性分析结果需足够把握度的试验确认。
- 样本量较小(完成研究57例)。
- 技术间阿片类药物相关差异是否超过运动阻滞顾虑需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral nerve blockade is a common analgesic technique in anterior cruciate ligament (ACL) reconstruction. The comparative opioid-sparing and functional outcomes of continuous femoral nerve block (CFNB) versus continuous adductor canal block (CACB) are unclear. METHODS: In this single-center, double-blind, prospective, superiority randomized controlled trial, 60 adults undergoing ACL reconstruction were randomized to receive either CFNB or CACB. All patients received a 20 mL loading dose of 0.5% ropivacaine and were discharged with a 0.2% ropivacaine infusion (5 mL/hour basal, 5 mL demand bolus, 30 min lockout). The primary outcome was average numeric rating scale (NRS) pain scores analyzed using a linear mixed-effects repeated-measures model over 48 hours. Secondary outcomes included cumulative morphine milligram equivalents (MME), continuous passive motion (CPM) usage, CPM compliance, and Quality of Recovery-15 (QoR-15) scores. RESULTS: 57 patients completed the study (CFNB n=28; CACB n=29). Mixed-effects repeated-measures analysis of average NRS pain scores at 24 and 48 hours showed no significant difference between CFNB and CACB. The estimated overall treatment effect for CFNB versus CACB was -0.31 NRS points (p=0.58, 95% CI -1.39 to 0.77), with no significant treatment-by-time interaction (p=0.97). Current NRS pain scores were lower for CFNB on postoperative day 0 (POD0) (p=0.02, 95% CI 6.44×10-6 to 2.00). In an exploratory analysis, fewer CFNB patients required more than 50 MME during the 48-hour follow-up period compared with CACB (CFNB: 5/28 vs CACB: 13/29; p=0.045, 95% CI 0.08 to 0.93). The absolute risk difference was 0.27 (95% CI -0.08 to 0.54). There were no differences in CPM use or compliance, bolus volume, or QoR-15. CONCLUSIONS: CFNB was not superior to CACB on the primary pain outcome over 48 hours. In secondary analysis, CFNB catheters were associated with lower immediate postoperative pain. In exploratory analyses, fewer patients required more than 50 MME over 48 hours. This finding is hypothesis-generating and requires confirmation in an adequately powered trial. There were no differences in quality of recovery or CPM compliance. Whether any opioid-related differences between techniques outweigh concerns about motor blockade warrants further investigation. TRIAL REGISTRATION NUMBER: NCT03208478.
引用
- Chen JC, Denoue CF, Horn A, et al. Continuous femoral nerve blocks versus adductor canal blocks for anterior cruciate ligament surgery: a double-blind, superiority randomized controlled trial. Reg Anesth Pain Med. 2026. PMID: 42481165. doi:10.1136/rapm-2026-107940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。